GBM AGILE Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GBM


Total Award Amount

  • 386846.00
  • Direct Costs

  • 322372.00
  • Sponsor Award Id

  • GCAR-7213
  • Contributor

  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Louis Nabors M.D.   Principal Investigator  
  • Mina Lobbous   Investigator  
  • Xiaosi Han   Investigator